(Total Views: 112)
Posted On: 04/12/2019 9:50:41 AM
Post# of 47163

$KTOV News Article - FameWave Announces Clinical Collaboration with Bristol Myers Squibb for the Planned Phase 1/2 Trial in Non-Small Cell Lung Cancer to Evaluate Immuno-Oncology Candidate CM-24 in Combination with Nivolumab (Opdivo ) https://marketwirenews.com/news-releases/fame...90492.html


My Twitter: WhyteStocks